Gainers & Losers
Mon Nov 25 2024 10:23:34- Larsen & Toubro share price
- ₹3,753.254.13%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
- Wipro share price
- ₹582.751.99%
- ICICI Bank share price
- ₹1,301.501.82%
Active Stocks
Mon Nov 25 2024 10:27:51- Adani Power share price
- ₹446.85-3.02%
- Power Grid Corporation Of ...
- ₹342.851.74%
- Tata Steel share price
- ₹143.600.56%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
Business News/Market/Market Stats/Emcure Pharmaceuticals share price/ Emcure Pharmaceuticals Profit Loss Annual
Emcure Pharmaceuticals Profit & Loss Annual
Trade1,317.55 +3.95 (0.30%)Updated : 25 Nov 2024
| Fiscal Period | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
| Revenue | 6,658.25 | 5,985.81 | 5,855.39 | 6,056.42 |
| Total Revenue | 6,658.25 | 5,985.81 | 5,855.39 | 6,056.42 |
| Costof Revenue Total | 2,595.46 | 2,369.11 | 2,330.43 | 2,626.86 |
| Gross Profit | 4,062.79 | 3,616.70 | 3,524.95 | 3,429.55 |
| Selling/ General/ Admin Expenses Total | 1,913.31 | 1,605.41 | 1,408.80 | 1,481.08 |
| Depreciation/ Amortization | 312.41 | 260.12 | 244.86 | 323.31 |
| Unusual Expense( Income) | 9.93 | 6.15 | - | 88.59 |
| Other Operating Expenses Total | 919.76 | 829.78 | 785.84 | 716.50 |
| Total Operating Expense | 5,750.87 | 5,070.56 | 4,769.93 | 5,236.35 |
| Operating Income | 907.39 | 915.25 | 1,085.46 | 820.07 |
| Interest Inc( Exp) Net- Non- Op Total | -1,583.83 | -1,319.45 | -854.89 | -1,344.31 |
| Gain( Loss)on Saleof Assets | 71.92 | -3.33 | -4.08 | 4.23 |
| Other Net | -28.97 | -35.76 | -27.02 | -28.73 |
| Net Income Before Taxes | 727.23 | 747.22 | 972.55 | 657.33 |
| Provisionfor Income Taxes | 199.65 | 185.37 | 269.99 | 238.73 |
| Net Income After Taxes | 527.58 | 561.85 | 702.56 | 418.59 |
| Minority Interest | -29.39 | -29.83 | -40.36 | -26.45 |
| Net Income Before Extra Items | 498.18 | 532.02 | 662.20 | 392.15 |
| Net Income | 498.18 | 532.02 | 662.20 | 392.15 |
| Income Availableto Com Excl Extra Ord | 498.18 | 532.02 | 662.20 | 392.15 |
| Income Availableto Com Incl Extra Ord | 498.18 | 532.02 | 662.20 | 392.15 |
| Diluted Net Income | 498.18 | 532.02 | 662.20 | 392.15 |
| Diluted Weighted Average Shares | 18.91 | 18.91 | 18.91 | 18.91 |
| Diluted EPS Excluding Extra Ord Items | 26.35 | 28.13 | 35.02 | 20.74 |
| Diluted Normalized EPS | 26.45 | 28.39 | 35.03 | 23.71 |
*All figures in crores except per share values
Emcure Pharmaceuticals Quick Links
Emcure Pharmaceuticals Dividend Emcure Pharmaceuticals Bonus Emcure Pharmaceuticals News Emcure Pharmaceuticals AGM Emcure Pharmaceuticals Rights Emcure Pharmaceuticals Splits Emcure Pharmaceuticals Board Meetings Emcure Pharmaceuticals Key Metrics Emcure Pharmaceuticals Shareholdings Emcure Pharmaceuticals Balance Sheet Emcure Pharmaceuticals Cashflow Emcure Pharmaceuticals Q1 Results Emcure Pharmaceuticals Q2 Results Emcure Pharmaceuticals Q3 Results Emcure Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
3,753.25+148.70(4.13%)
844.75+28.70(3.52%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)